Skip to content
MRI Brain

Depression Biotypes Multisite rsfMRI (Drysdale 2017)

Multisite resting-state fMRI sample of the depression biotypes study (Weill Cornell, Drysdale et al. 2017)

Pooled resting-state fMRI and T1-weighted MRI of 1,188 adults (458 with major depression, 730 healthy controls) from 17 sites, led by Weill Cornell, used to define four connectivity biotypes of depression. Patient sites share data at the investigators' discretion.

Overview

This entry describes the pooled multisite sample behind the depression biotypes study of Drysdale, Liston and colleagues at Weill Cornell Medical College (Nature Medicine, 2017). The authors clustered resting-state functional connectivity of patients with major depression into four subtypes and trained classifiers to assign them. The paper treats its scans as one large multisite data set, split into a training set and an independent replication set. The sites carry labels such as Cornell 1, Cornell 2, Toronto and Stanford 1.

Composition

The sample has 1,188 adults. Data set 1 (training) holds 333 patients in a current major depressive episode and 378 healthy controls from 12 sites. Data set 2 (replication) holds 125 patients (109 unipolar, 16 bipolar II) and 352 controls from 13 sites, five of them new. Supplementary Table 3 lists 17 site labels in total. Cornell 1 contributed 96 patients and 28 controls to data set 1 and 35 patients and 35 controls to data set 2. Cornell 2 contributed 27 patients and 8 controls to data set 2. Clustering used 220 patients from Cornell 1 and Toronto, two sites with the same inclusion criteria (treatment-resistant unipolar depression). Fifty Cornell 1 patients had a second scan 4 to 5 weeks later, and 124 Toronto patients had imaging before a course of rTMS to the dorsomedial prefrontal cortex. The study also used 39 patients with generalized anxiety disorder (Cornell 1 and Stanford 1) and 41 with schizophrenia (COBRE), which are not counted in the 1,188.

Acquisition

Each subject had a resting-state BOLD scan (spiral in-out or Z-SAGA) and a T1-weighted MP-RAGE or SPGR scan. Parameters differ by site; most used a TR near 2 s, about 3.5 mm in-plane resolution and 150 to 180 volumes. Cornell 1 and Toronto scanned on 3T GE Signa systems with 180 and 300 volumes. Depression severity was rated with the 17-item Hamilton scale.

Annotations

No image annotations. Labels are diagnosis, Hamilton item scores, biotype assignment and, for the Toronto rTMS group, treatment response.

Known limitations

  • No public release of the patient sites. Sharing is left to each site investigator, with no published terms.
  • Controls from ten sites come from the 1000 Functional Connectomes Project and are tracked there.
  • Inclusion criteria, medication use and comorbidities differ by site.
  • Sex is reported only as percentages per group and site, and scanner models only for Cornell 1 and Toronto.

Cohort

Aggregate numbers from the sources below. Bars are relative to the 1,188 subjects.

Modality

subjects

  • MRI 1,188 100%

Contrast / sequence

subjects, values can overlap

  • BOLD fMRI 1,188 100%
  • T1-weighted 1,188 100%

Condition

subjects, values can overlap

  • Healthy control 730 61%
  • Major depressive disorder 458 39%

Scanner vendor

subjects

  • GE HealthCare 220 19%

Field strength

subjects

  • 3 T 220 19%

Split

subjects

  • Training 711 60%
  • Test 477 40%

License and access

Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer

Access
On request

Ask the authors or the data holder. No published process or terms, and access is at their discretion

The data availability statement says that data from the sites outside the 1000 Functional Connectomes Project are available at the discretion of the site principal investigators named in Supplementary Table 2 (Cornell 1: Dubin and Liston; Toronto: Downar; Emory 1: Mayberg; Stanford 1: Etkin; Stanford 2: Schatzberg). Control and COBRE data from NKI, Atlanta, Cambridge, Cleveland, ICBM, New York, COBRE, Beijing, Milwaukee and Leipzig are public through the 1000 Functional Connectomes Project.

Access page

Different parts of the data carry different licenses. The summary on the right shows the most restrictive answer per rule.

For Patient and control scans from the investigator-held sites (Cornell 1, Cornell 2, Emory 1, Stanford 1, Stanford 2, Toronto and Harvard).

No published license or data use terms

The data holder has published no license and no data use terms. Any use, sharing or commercial right has to be agreed with the data holder, and nothing can be assumed to be allowed. Default copyright and data protection law still apply.

The paper's data availability statement leaves sharing to the site investigators and states no terms.

Original license text Checked 2026-10-08

What you can do

  • Commercial use Not stated
  • Not stated
  • Train ML models Not stated
  • Create derived data Not stated
  • Publish results Not stated

What you can share

  • Share the data Not stated
  • Share derived data Not stated
  • Share trained models Not stated

What you must do

  • Cite or credit Not stated
  • Share alike Not stated
  • Sign an agreement Not stated
  • Ethics approval Not stated
  • Manuscript review Not stated
  • Release code Not stated
  • Return results Not stated
  • Delete after use Not stated

Limits

  • No re-identification Not stated
  • Location limits Not stated
For Scans from the sites the paper names as publicly available through the 1000 Functional Connectomes Project (NKI, Atlanta, Cambridge, Cleveland, ICBM, New York, COBRE, Beijing, Milwaukee and Leipzig).

1000 Functional Connectomes Project / INDI terms (Creative Commons Attribution Non-Commercial, no version stated)

Non-commercial use only, after registering with the 1000 Functional Connectomes Project on NITRC. The NITRC project lists a Creative Commons Attribution Non-Commercial license without a version: derived works must credit the source and stay non-commercial but need not use the same license.

Original license text Version read: License field "Attribution Non-Commercial" on the NITRC fcon_1000 project page (no Creative Commons version named) and the access statement on the INDI home page, read 2026-10-08 Checked 2026-10-08

What you can do

  • No
  • Not stated
  • Not stated
  • Conditional
  • Not stated

What you can share

  • Not stated
  • Conditional
  • Share trained models Not stated

What you must do

  • Yes
  • No
  • Conditional
  • Ethics approval No
  • Manuscript review No
  • Release code No
  • Return results No
  • Delete after use No

Limits

  • No
  • Location limits No

Commercial license: Not stated

Citation

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nature Medicine 23(1):28-38 (2017). doi:10.1038/nm.4246

All numbers

Every number on this page, as stored in stats.csv, with its source.

MeasureBreakdownValueSource
Subjectstotal
data set 1 (711) plus data set 2 (477); excludes the separate GAD (39) and schizophrenia (41) cohorts
1,188drysdale2017
Abstract
Subjectsmodality=MR 1,188drysdale2017
Online Methods: MRI data acquisition
Subjectscontrast=bold
resting-state fMRI in all subjects
1,188drysdale2017
Online Methods: MRI data acquisition
Subjectscontrast=T1w
MP-RAGE or SPGR anatomical scan for parcellation and co-registration
1,188drysdale2017
Online Methods: MRI data acquisition
Subjectssplit=train
data set 1 (training set)
711drysdale2017
Online Methods: Subjects
Subjectssplit=test
data set 2 (independent replication set)
477drysdale2017
Online Methods: Subjects
Subjectscondition=depression
333 patients in data set 1 plus 125 in data set 2; the sum matches the stated total of 1,188
458drysdale2017
Online Methods: Subjects
Subjectscondition=healthy
378 controls in data set 1 plus 352 in data set 2; the sum matches the stated total of 1,188
730drysdale2017
Online Methods: Subjects
Subjectscondition=depression;split=train
current major depressive episode
333drysdale2017
Online Methods: Subjects
Subjectscondition=healthy;split=train 378drysdale2017
Online Methods: Subjects
Subjectscondition=depression;split=test
109 unipolar and 16 bipolar II
125drysdale2017
Online Methods: Subjects
Subjectscondition=healthy;split=test 352drysdale2017
Online Methods: Subjects
Mean agecondition=depression;split=train 40.6drysdale2017
Online Methods: Subjects
Mean agecondition=healthy;split=train 38drysdale2017
Online Methods: Subjects
Mean agecondition=depression;split=test 49.8drysdale2017-si
Supplementary Table 3
Mean agecondition=healthy;split=test 32.1drysdale2017-si
Supplementary Table 3
Subjectsvendor=ge
GE Signa 3T; Cornell 1 (96) and Toronto (124) patients of the cluster-discovery set; scanners of the other sites are not reported
220drysdale2017-si
Supplementary Table 1
Subjectsfield_strength=3
Cornell 1 and Toronto patients of the cluster-discovery set
220drysdale2017-si
Supplementary Table 1

Sources

The keys used in the table above.